Spontaneous motor activity and brain catecholamines in C57BL/6 and albino mice treated with manganese;Actividad motora espontánea y catecolaminas en cerebro de ratones negros C57BL/6 y albinos tratados con manganeso

Investigacion Clinica

Volumn 45, Issue 1, 2004, Pages 3-15

  Martínez, Humberto José ^a   Castro Caraballo, Fidel ^b   Arrieta, Arelis ^b   Bonilla, Ernesto ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Fundacite Zulia   (Venezuela)

Author keywords

C57BL 6 mice; Catecholamines; Locomotor activity; Manganese

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ADRENALIN; BRAIN MONOAMINE; CATECHOLAMINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MANGANESE; NORADRENALIN; SEROTONIN;

ADRENALIN BRAIN LEVEL; ARTICLE; CATECHOLAMINE BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; LOCOMOTION; LOCUS CERULEUS; MOTOR ACTIVITY; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; SEROTONIN BRAIN LEVEL; STRAIN DIFFERENCE; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CATECHOLAMINES; MALE; MANGANESE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY;

EID: 1942533599     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bonilla E, Levine S, de Salazar E. Intoxicación crónica con manganeso. Acta Cient Vzlana 1978; 29:332-337.
2. McNally WD. Industrial manganese poisoning with a review of the literature. Industr Med 1935; 4:458-599.
3. Barbeau A. Manganese and extrapyramidal disorders. Neurotoxicology 1984; 5:13-36.
4. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974; 30:59-64.
5. Canavan MM, Cobb S, Drinker CK. Chronic manganese poisoning. Report of a case, with autopsy. Arch Neurol Psychiat (Chicago) 1934; 32:501-512.
6. Chandra SV, Srivastava SP. Experimental production of early brain lesion in rats by parenteral adminstration of manganese chloride. Acta Pharmacol Et Toxicol 1970; 28:177-183.
7. Cardozo J, Bonilla E. The neuropathology of experimental chronic manganese poisoning in ratas. A preliminary report. Invest Clin 1985; 26:117-124.
8. Bonilla E. El manganeso y su importancia biomédica. Ediciones Astro Data SA, Maracaibo, Venezuela. 1987.
9. Przedborski S, Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov Disor 1998; 13(Suppl):35-38.
10. D'Amato RJ, Lipman ZP, Zinder SII. Selectivity of the parkinsonian neurotoxin MPTP. Toxic metabolite MPP+ binds to neuromelanin. Science 1986; 231:987-989.
11. Donaldson J, Labellal FS, Gesser D. Enhanced autoxidation of dopamine and a possible basis of manganese neurotoxicity. Neurotoxicology 1981; 2:53-64.
12. Graham DG. Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese. Neurotoxicity and Parkinson's disease. Neurotoxicology 1984; 45:83-96.
13. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219:979-980.
14. Burns RS, Chiueh CC, Markey SP, Ebert MII, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U.S.A. 1983; 80:4546-4550.
15. Langston JW, Forno LS, Rebert CS, Irwing I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1-2,3,6-tetrahydropyridine (MPTP) in the squirrel monkeys. Brain Res 1984; 292: 390-394.
16. Heikkila RE. 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP). A dopamin-ergic neurotoxin. Neurotransmissions 1988; 4:1-4.
17. Tipton KF, Singer TP. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 1993; 61:1191-1206.
18. Puglisi-Allegra S, Cabib S. Psycho pharmacology of dopamine. The contribution of comparative studies in inbread strains of mice. Prog Neurobiol 1997; 51:637-661.
19. Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of MPTP in mice. Science 1984; 244:1451-1453.
20. Talavera EJ, Arcaya JL, Giraldoth D, Suárez J, Bonilla E. Decrease in spontaneous motor activity and in brain lipid peroxidation in manganese and melatonin treted mice. Neurochem Res 1999; 24(5): 705-708.
21. Cuesta de DiZio MC, Gómez G., Bonilla E, Suárez-Roca II. Auroreceptor presynaptic control of dopamine release from striatum is lost at early stages of manganese poisoning. Life Sci 1995; 56(22):1857-1864.
22. Glowinski J, Iversen L. Regional studies of catecholamines in rat brain. I. The disposition of 3H-dopamine and 3H-dopa in various regions of the brain. J Neurochem 1966; 13:655-669.
23. Bonilla E, Prassad ALN. Effect of chronic manganese intake on the levels of biogenic amines in rat brain regions. Neurobehav Toxicol Teratol 1984; 6:341-344.
24. Cano G, Suárez-Roca, Gómez G, Arcaya JL, Aversano G, Latan JC, Bonilla E. Alterations of animal motor activity in early stages of experimental manganese poisoning. In: Metal Ions in Biology and Medicine, Vol 4, Collery Ph, Corbella J, Domingo JL, Etienne JC and Llobat JM (Eds). Paris: John Libbery Eurotext; 1996. PP 472-474.
25. Messiha FS, Martin NJ, Bucher KD. Behavioral and genetic interrelationships between locomotor activity and brain biogenic amines. Gen Pharmacol 1990; 21(4):459-464.
26. Belknap JK, Crabbe JC, Young ER. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 1993; 112(4):503-510.
27. George SR, Fan T, Ng G YK, Jung SY, O'Dowd BF, Naranjo CA. Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: Reversal by increasing synaptic dopamine. J Pharmacol Exp Ther 1995; 273(1) 373-379.
28. 3H-tomoxetine. Neurosci Lett 1999; 265: 151-154.
29. Bonilla E, Diez-Ewald M. Effect of L-DOPA on brain concentration of dopamine and homovanilic acid in rats after chronic manganese chloride administration. J Neurochem 1974; 2:297-299.
30. Deskin RS, Bursian J, Edenis FW. Neurochemical alterations induced by manganese chloride in neonatal rats. Neurotoxicology 1980; 2:65-73.
31. Chandra SV, Shukla GS, Saxena DK. Manganese induced behavioral dysfunction and its neurochemical mechanisms in growing mice. J. Neurochem 1979; 33:1217-1221.
32. Cotzias GC, Papavaseliou PG, Mena I, Tang LC, Miller ST. Manganese and catecholamines. In: F McDowell and A Barbeau, Eds. Advances in Neurology, vol 5: Second Canadian-American Conference on Parkinson's Disease. New York: Raven Press; 1974. PP 235.
33. Alousi A, Weiner N. The regulation of norepinephrine synthesis in sympathetic nerves: Effect of nerve stimulation, cocaine and catcholamine-releasing agents. Proc Natl Acad Sci U.S.A. 1966; 56:1491-1496.
34. Levitt MS, Spector A, Sjoerdesina A, Vdenfriend S. Elucidation of the rate-limiting step in NE byosynthesis in the perfused guinea pig-heart. J Pharmacol Exp Ther 1965; 148:1-8.
35. Bacopolous NG, Bhartnagar RK. Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions. J Neurochem 1977; 29:639-643.
36. Bonilla E. L-tyrosine hydroxylase activity in rat brain after chronic oral administration of manganese chloride. Neurobehav Toxicol 1980; 2:37-41.
37. Weiner N, Molinoff P.B. Catecholamines In: G.S. Siegel, B.W. Agranoff, R.W. Albers, P.B. Rodisioff, Eds. Basic Neurochemistry. New York: Raven Press; 1994.
38. Ng GY, O'Dowd BF, George SR. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains. Eur J Pharmacol 1994; 269(3):394-364.
39. Amsman II, Zacharko RM. Múltiple neurochemical and behavioral consequences of stressors: Implications for depresión. Pharmacol Ther 1990; 46: 119-136.
40. Kostoswski W, Plaznik A, Danysz W. The role of the locus coeruleus-limbic noradrenergic transmission in the action of antidepressant drugs. Phychopharmacol Bull 1986; 22:512-522.
41. Simson PG, Weiss JM. Altered activity of the locus coesuleus in an animal model of depression. Neuropsychopharmacology 1988; 1:287-295.